Racklify

News

LogiCare3PL Becomes Exclusive Logistics Partner for ChiRhoClin’s ChiRhoStim®

LogiCare3PL, a division of BioCare, Inc., has been selected as the exclusive third-party logistics provider for ChiRhoClin’s flagship diagnostic product, ChiRhoStim® (Human Secretin for Injection). The partnership, effective July 14, 2025, underscores both companies’ commitment to high-touch, patient-centered care, particularly in the orphan drug space. With cGMP-compliant and NABP®-accredited distribution centers in Arizona and Mississippi, LogiCare3PL is well positioned to support the secure, reliable delivery of this critical gastrointestinal diagnostic therapy.

William
William Carlin

18 Jul 2025 1:42 PM

LogiCare3PL Becomes Exclusive Logistics Partner for ChiRhoClin’s ChiRhoStim®
HotNotes
  • Exclusive Partnership: LogiCare3PL is now the sole 3PL provider for ChiRhoClin’s ChiRhoStim®, a leading diagnostic therapy for pancreatic and GI conditions.
  • pecialized Logistics: LogiCare3PL brings accredited, cGMP-compliant pharmaceutical facilities and deep expertise in orphan drug distribution.
  • Shared Mission: Both organizations emphasize precision, reliability, and patient-focused service in advancing diagnostic healthcare.
  • LogiCare3PL Becomes Exclusive Logistics Partner for ChiRhoClin’s ChiRhoStim®


    LogiCare3PL, a division of BioCare, Inc., has announced a new strategic partnership with ChiRhoClin, Inc., a leader in pancreatic and gastrointestinal diagnostics. As of July 14, 2025, LogiCare3PL will serve as the exclusive third-party logistics (3PL) provider for ChiRhoStim® (Human Secretin for Injection), ChiRhoClin’s flagship diagnostic product.


    Supporting Critical Care with Precision Logistics


    The partnership strengthens ChiRhoClin’s distribution capabilities for ChiRhoStim®, a diagnostic tool widely used in gastroenterology, while aligning with LogiCare3PL’s specialized expertise in orphan drug logistics. Known for its high-touch, patient-centered approach, LogiCare3PL provides full-service pharmaceutical logistics through secure, accredited facilities in Tempe, Arizona, and Olive Branch, Mississippi.


    “We’re proud to support ChiRhoClin in distributing ChiRhoStim®, a diagnostic product that plays a vital role in patient care,” said Kevin Kissling, Vice President & General Manager of LogiCare3PL. “Our team appreciates the importance of reliability and precision in handling sensitive therapies like ChiRhoStim®, and we are committed to delivering a seamless and dependable experience for ChiRhoClin’s customers.”


    Accredited Facilities Purpose-Built for Orphan Drug Distribution


    LogiCare3PL’s facilities are cGMP-compliant and accredited by the National Association of Boards of Pharmacy® (NABP®), with the capabilities to handle both domestic and international pharmaceutical distribution. The partnership underscores the importance of specialized 3PL solutions for small-batch, high-value medications, especially in rare disease diagnostics.


    A Confident Step Forward for ChiRhoClin


    “The LogiCare3PL team has been a proactive and engaged partner as we prepared to distribute ChiRhoStim® through the company’s distribution network,” said Skip Purich, CEO of ChiRhoClin. “Their experience in orphan drug logistics has been critical to establishing a strong foundation for this launch.”


    About LogiCare3PL


    LogiCare3PL, a BioCare, Inc. division, is a nationally accredited logistics provider focused on high-value pharmaceutical products. It specializes in orphan and specialty drug distribution, offering compliant and secure logistics services that prioritize reliability and patient care.


    About ChiRhoClin, Inc.


    ChiRhoClin is a Maryland-based pharmaceutical company dedicated to advancing orphan drug products for pancreatic and gastrointestinal diseases. In addition to ChiRhoStim®, the company supports research through its Small Pancreatic Grant Program, emphasizing innovation in diagnostic and therapeutic solutions.

    Subscribe to Racklify News for up-to-date Logistics News & Events

    Comments


    Share this on Social Media:

    logo

    News

    Processing Request